D
Cartesian Therapeutics, Inc. RNAC
$10.78 -$0.47-4.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 189.70% -72.73% 57.60% -274.78% 124.35%
Total Depreciation and Amortization -49.05% 137.86% 69.93% 45.92% 7.10%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -6,253.03% 112.93% -134.65% 227.19% -92.36%
Change in Net Operating Assets 78.71% -203.43% -73.47% 180.46% -403.66%
Cash from Operations 24.18% -230.02% -151.14% 194.77% 9.24%
Capital Expenditure -141.40% -52.48% 88.63% -290.61% -163.62%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -141.40% -203.67% 94.29% -290.61% -163.62%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -53.55% -78.45% -99.32% 103,645.00% -96.04%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- -100.00%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 99.70% -12,336.36% -- -- --
Cash from Financing 100.75% -1,124.90% -99.37% 103,645.00% -99.72%
Foreign Exchange rate Adjustments -62.50% 313.33% 0.00% -207.14% 380.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 37.71% -388.40% -104.99% 930.06% -159.98%